World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-4b45px
Date of registration: 10/04/2012
Primary sponsor: Centro de Pesquisa Fima Lifshitz - Salavdor, BA, Brazil
Public title: Comparison of methods of oral rehydration therapy in children with acute diarrhea.
Scientific title: Comparison of methods of oral rehydration therapy in children with acute diarrhea.
Date of first enrolment: 01/03/2011
Target sample size: 70
Recruitment status: data analysis completed
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-4b45px/
Study type: 
Study design:  Therapeutic, controlled, parallel, with 2 arms, single-blinded, randomized clinical trial.
 
Countries of recruitment
Brazil
Contacts
Name: Hugo  Ribeiro Jr
Address:  Rua Padre Feijó, número 29/ Canela 40110-160 Salvador Brazil
Telephone: (55 71) 3283-8100
Email: hugocrj@ufba.br
Affiliation:  Centro de Pesquisa Fima Lifshtz/UFBA
Name: Patricia  Mendes
Address:  Rua Padre Feijó, número 29/ Canela 40110-160 Salvador Brazil
Telephone: (55 71) 3283-8346
Email: pat-almeida@ig.com.br
Affiliation:  Centro de Pesquisa Fima Lifshtz/UFBA
Key inclusion & exclusion criteria
Inclusion criteria: Male children 2-30 months old
Pre-classified with acute diarrhea and dehydration.

Exclusion criteria: Only breastfeeding nutrition
With severe malnutrition
With clinical suspicious or documented signs and symptoms of chronic illness or systemic infection
Not able to understand the nature of study and sign the inform consent


Age minimum: 2M
Age maximum: 30M
Gender: M
Health Condition(s) or Problem(s) studied
A00-B99
Children hospitalized with acute diarrhea and dehydration
C23.888.821.214.500
Intervention(s)
Group A (standard):Thirty-four children received during the maintenance phase of the standard Oral Rehydration Solution (ORS) with 90mmol/L sodium, 111mmol/L glucose and osmolarity of 311mmol/L, in equal volumes of the abnormal losses, in addition to free water and diet appropriate for their age.Until the cessation of diarrhea.
Group B (test): Thirty-six children in this group had made the replacement of abnormal losses with the same solution with a calculated volume that results from subtraction of the ingest the liquid diet (milk formula, breast milk, liquid soup and juice and water intake), using a formula for Balance Intake Minus Loss (BIML) in which BIML is equal to intake liquid in milliliter (ILmL) minus abnormal losses milliliter (ALmL). Formula: BIML=ILmL-ALml . Until the cessation of diarrhea
Primary Outcome(s)
Reduction of the duration of diarrhea (hours), as well as stool output (ml / kg / h) due to a lower water intake (ml / kg / day) without an increase in dehydration.
Water Balance held every 8hours:
All losses (faeces, vomit and urine output) collected in containers and clothing pre-weighed were measured on precision scales (OHAUS Triple Beam Balance Model, 2610 g capacity 5lb 2oz).
All oral intake was measured using the technique of rest-intake using a precision scale (DIGIPESO, model DP-3000, 3 kg capacity and accuracy 0.5 g).
Secondary Outcome(s)
No impairment in weight gain or caloric intake,
No increase in the number of vomiting, nor
disorder hydroelectrolytical.
The weight of each naked child was obtained in the same time (06, 14 and 22h) and before the meals using digital scale balance model BP Fillizola Baby™ with accuracy of 5grams.
For the measurement of caloric intake and vomiting, was performed the same procedure performed for the primary outcomes.
Electrolyte abnormalities (hypernatremia (Na> 150mmol / l), hyponatremia (Na <130 mmol / l) and hypokalemia (K <3 mmol / l)) were evaluated by laboratory tests.
Secondary ID(s)
121/2003
Source(s) of Monetary Support
Fundação de Apoio à Pesquisa do Estado da Bahia- FAPESB - Salvador, BA, Brazil
Secondary Sponsor(s)
Universidade Federal da Bahia - Salvador, BA, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history